CERO Report - Sevenich Lab supported by OLS
Establishing Murine aNSC-Based Protocols Using the CERO Bioreactor
This project marks the first use of the CERO bioreactor for culturing murine aNSCs, developing cerebral organoids, and brain cancer assembloids. While CERO has been tested with human stem cells, we evaluated its performance with murine aNSCs, comparing it to traditional well-plate methods. Results were analyzed for scalability, growth dynamics, and long-term culture stability.
Scalability
Handling larger cell cultures
with less manual work and
greater consistency.
Growth Dynamics
Achieving more controlled
growth and less frequent
splitting and manual labor.
Long-Term Culture
Sustaining organoid growth
over extended periods with
consistent shape and
minimal intervention.
Key Findings
The following highlights showcase the superior performance of the CERO bioreactor in culturing murine adult neural stem cells (aNSCs) and cerebral organoids.These key facts demonstrate its advantages in terms of scalability, efficiency, and long-term culture, improving traditional culture methods.
20x
Higher aNSCs culture capacity
Supports up to 50 million cells per tube, compared to traditional well-plate methods.
5 days
For initial neurosphere formation with slow controlled growth and minimal clumping.
2-4x
Less frequent aNSCs splitting
Continuous movement delays early neurosphere formation, reducing the need for frequent passaging.
50 %
Reduction in manual labor
Fewer media changes and less hands-on time compared to well-plate cultures.
> 200
Cerebral organoids
grown per CERO tube, ensuring large-scale organoid production.
> 5
Months
of stable organoid culture with consistent shape and size.
Cerebral organoid after 3-month cultuvation
(6-well suspension plate/orbital shaker)
Characterized by uneven size distribution, oval shapes, and apoptotic cores
Cerebral organoid after 5-month cultivation
(CERO 3D Incubator and Bioreactor)
haracterized by even size distribution, round shapes, and proliferating cores.
Scalability
6-Well Suspension Plate/Orbital Shaker:
- Limited Capacity: Supports ~10-30 organoids per well, but as they grow, organoids tend to touch the bottom, impacting growth.
- Size Variability: Organoids larger than 800 µm often develop uneven sizes and doughnut shapes due to space constraints and inconsistent mixing.
CERO 3D Incubator and Bioreactor:
- High Capacity: Cultures 200+ organoids per tube, significantly increasing throughput.
- No Fusion: Constant movement prevents fusion of organoids, maintaining controlled growth.
- More Efficient: Larger media volume reduces the need for frequent media changes, saving resources and time.
Growth Dynamics
6-Well Suspension Plate/Orbital Shaker:
- Uneven Growth: Organoids show size variation and tend to flatten or form doughnut shapes once they grow over 800 µm.
- Bottom Contact: Organoids settle on the well bottom, disrupting uniform growth.
CERO 3D Incubator and Bioreactor:
- Controlled Growth: Slower initial formation allows for even, round organoids, preventing early fusion.
- Consistent Suspension: Organoids stay in suspension, avoiding bottom contact and ensuring uniform growth and nutrient access.
Long-Term Culture
6-Well Suspension Plate/Orbital Shaker:
- Viability Declines After 3 Months: Larger organoids develop apoptotic cores and require replacement.
CERO 3D Incubator and Bioreactor:
- Stable for 5+ Months: Organoids remain viable with proliferating cores, round shapes, supporting extended culture without renewal.
Glioma assembloid
(6-well suspension plate/orbital shaker)
Glioma assembloid
(CERO 3D Incubator and Bioreactor)
Revolutionizing
Assembloid Culture
Cerebral Assembloids: A 3D Co-Culture Model
Cerebral assembloids, a co-culture of fused cerebral organoids and cancer spheroids, are an emerging 3R-compliant 3D model, offering an alternative to in vivo studies. Their key advantage lies in the ability to recapitulate both healthy and pathological tissue, closely mimicking conditions observed in cancer patients. However, despite their potential, assembloids have limitations. Both cerebral organoids and spheroids are spherical structures placed together, but their interaction sites are limited, with typically less than 10% of their surface areas interconnected. This does not represent the clinical scenario, where brain cancer is often fully surrounded by healthy brain tissue, creating more complex tumor microenvironment (TME) interactions.
In our proof-of-concept study, we demonstrate that the CERO bioreactor overcomes this limitation, producing assembloid models with over 50% interconnected surface areas, a significant improvement that better reflects the tumor-tissue interactions seen in clinical settings.
Procedure Summary
Previously differentiated cerebral organoids cultured were co-cultured with GL261 glioma spheroids (seeded at 10,000 cells per well in a 96-well ULA plate and pre-incubated for 3 days). Organoids and spheroids were placed together in a new 96-well ULA plate, allowing tight cell-cell connections to form over 72 hours. After 72 hours, half of the assembloids were transferred to a CERO tube, while the other half remained in the 96-well ULA plate. After an additional 48 hours (a total of 120 hours), assembloids were fixed, sectioned, and stained using H&E, Ki-67 and Cas-3 for analysis.
KI-67 Proliferation Marker
CAS-3 Apoptosis Marker
Scalability
96-Well ULA Plate:
-
Small-Scale Capacity: Supports individual
assembloid formation but is limited by the
number of wells.
CERO 3D Incubator and Bioreactor:
- Enhanced Complexity: The primary strength lies in the greater model sophistication.
- Multiple Assembloids: Several assembloids
can be cultured in a single CERO tube.
Growth Dynamics
96-Well ULA Plate
- Limited Interaction: Less than 10% surface interconnection between organoids and glioma spheroids, leading to weaker tumororganoid interaction.
- Decreased Proliferation: Ki-67 staining shows reduced proliferation in the organoid part of the assembloid over prolonged culture.
- Increased Apoptosis: Cas-3 staining reveals
higher levels of apoptosis in the organoid
tissue compared to the CERO model.
CERO 3D Incubator and Bioreactor:
- Improved Fusion: Promotes over 50% surface interconnection between organoids and tumor spheroids.
- In Vivo Mimicry: Closely mimics tumor invasion, with H&E staining showing cerebral organoids growing around more than half of the tumor tissue.
- Increased Proliferation: Ki-67 staining reveals proliferation in both glioma and organoid tissues.
- Enhanced Viability: Cas-3 staining shows
less apoptosis, indicating improved cell
viability compared to the ULA plate.
Long-Term Culture
96-Well ULA Plate:
- Limited Interaction: Organoid-tumor fusion remains weak, affecting the robustness of long-term studies.
- Higher Apoptosis: Increased apoptosis rates,
as shown by Cas-3 staining, reduce the
model’s viability for extended research.
CERO 3D Incubator and Bioreactor:
- mproved Fusion: Enhanced organoidtumor interaction supports better longterm culture.
- Reduced Apoptosis: Lower levels of
apoptosis with proliferating cores in both
glioma and organoid tissues create a more
stable, long-lasting model.
Special Thank You
We are truly grateful to Dr. Andreas Friese and Dr. Markus Uhrig at OLS OMNI Life Science for giving us the opportunity to work with the CERO. Your support and specialist training have been invaluable and it has been a pleasure collaborating with both of you. We look forward to continuing our joint work, now focusing on brain slice cultivation.
Anna Wolfram, Vanessa Arnold & Prof. Dr. Lisa Sevenich
aNSCs and Assembloids Culture - Request a Free Demo Today
Scale up your aNSCs and assembloids culture with CERO 3D. Achieve efficient results with a streamlined, cost-effective workflow. The CERO 3D Incubator & Bioreactor enables automated culture, ensuring homogeneous cell aggregates and robust scalability.
Optimize your aNSCs and assembloids culture with CERO 3D.
Request a free demo today!
Request a Free Demo